Report Detail
(Post-pandemic Era)-Global Biosimilars/follow-on-biologics Market Segment Research Report 2022
- RnM4476979 |
- 04 August, 2022 |
- Global |
- 107 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Biosimilars/follow-on-biologics Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Biosimilars/follow-on-biologics industry at home and abroad, estimate the overall market scale of the Biosimilars/follow-on-biologics industry and the market share of major countries, Biosimilars/follow-on-biologics industry, and study and judge the downstream market demand of Biosimilars/follow-on-biologics through systematic research, Analyze the competition pattern of Biosimilars/follow-on-biologics, so as to help solve the pain points of various stakeholders in Biosimilars/follow-on-biologics industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Biosimilars/follow-on-biologics Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Biosimilars/follow-on-biologics Market?
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Major Type of Biosimilars/follow-on-biologics Covered in XYZResearch report:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Application Segments Covered in XYZResearch Market
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Biosimilars/follow-on-biologics Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Biosimilars/follow-on-biologics Market by Value
- 2.2.1 Global Biosimilars/follow-on-biologics Revenue by Type
- 2.2.2 Global Biosimilars/follow-on-biologics Market by Value (%)
- 2.3 Global Biosimilars/follow-on-biologics Market by Production
- 2.3.1 Global Biosimilars/follow-on-biologics Production by Type
- 2.3.2 Global Biosimilars/follow-on-biologics Market by Production (%)
3. The Major Driver of Biosimilars/follow-on-biologics Industry
- 3.1 Historical & Forecast Global Biosimilars/follow-on-biologics Demand
- 3.2 Largest Application for Biosimilars/follow-on-biologics (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Biosimilars/follow-on-biologics Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Biosimilars/follow-on-biologics Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Biosimilars/follow-on-biologics Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Biosimilars/follow-on-biologics Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Biosimilars/follow-on-biologics Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Biosimilars/follow-on-biologics Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Biosimilars/follow-on-biologics Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Biosimilars/follow-on-biologics Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Biosimilars/follow-on-biologics Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Biosimilars/follow-on-biologics Average Price Trend
- 12.1 Market Price for Each Type of Biosimilars/follow-on-biologics in US (2018-2022)
- 12.2 Market Price for Each Type of Biosimilars/follow-on-biologics in Europe (2018-2022)
- 12.3 Market Price for Each Type of Biosimilars/follow-on-biologics in China (2018-2022)
- 12.4 Market Price for Each Type of Biosimilars/follow-on-biologics in Japan (2018-2022)
- 12.5 Market Price for Each Type of Biosimilars/follow-on-biologics in India (2018-2022)
- 12.6 Market Price for Each Type of Biosimilars/follow-on-biologics in Korea (2018-2022)
- 12.7 Market Price for Each Type of Biosimilars/follow-on-biologics in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Biosimilars/follow-on-biologics Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Biosimilars/follow-on-biologics
14. Biosimilars/follow-on-biologics Competitive Landscape
- 14.1 Novartis (Sandoz)
- 14.1.1 Novartis (Sandoz) Company Profiles
- 14.1.2 Novartis (Sandoz) Product Introduction
- 14.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 Synthon Pharmaceuticals
- 14.2.1 Synthon Pharmaceuticals Company Profiles
- 14.2.2 Synthon Pharmaceuticals Product Introduction
- 14.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 Teva Pharmaceutical Industries
- 14.3.1 Teva Pharmaceutical Industries Company Profiles
- 14.3.2 Teva Pharmaceutical Industries Product Introduction
- 14.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 LG Life Sciences
- 14.4.1 LG Life Sciences Company Profiles
- 14.4.2 LG Life Sciences Product Introduction
- 14.4.3 LG Life Sciences Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 Celltrion Biocon
- 14.5.1 Celltrion Biocon Company Profiles
- 14.5.2 Celltrion Biocon Product Introduction
- 14.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Hospira
- 14.6.1 Hospira Company Profiles
- 14.6.2 Hospira Product Introduction
- 14.6.3 Hospira Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 Merck Serono (Merck)
- 14.7.1 Merck Serono (Merck) Company Profiles
- 14.7.2 Merck Serono (Merck) Product Introduction
- 14.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Biogen idec
- 14.8.1 Biogen idec Company Profiles
- 14.8.2 Biogen idec Product Introduction
- 14.8.3 Biogen idec Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 Genentech (Roche)
- 14.9.1 Genentech (Roche) Company Profiles
- 14.9.2 Genentech (Roche) Product Introduction
- 14.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Biosimilars/follow-on-biologics. Industry analysis & Market Report on Biosimilars/follow-on-biologics is a syndicated market report, published as (Post-pandemic Era)-Global Biosimilars/follow-on-biologics Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Biosimilars/follow-on-biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
